仲恩影片圖卡.001

Unique Therapeutic 

Through the isolation, purification and cultivation processes in Steminent’s system, Stemchymal® possesses unique therapeutic advantages in:

  • In vivo sustainability – Stemchymal® can exert sustainable therapeutic effects with more effective cell number required.
  • Immunomodulatory ability – Stemchymal® presents superior T-cell modulation ability.
  • Homing ability – Stemchymal® can migrate and engraft into the specific injured site in a more effective fashion.
  • Multipotent differentiation ability — Stemchymal®, under Steminent’s technology platform, are able to differentiate into specialized cell types from mesoderm, endoderm and ectoderm.

Product Safety

As a therapeutic biologic for allogeneic use, Stemchymal® has demonstrated evidence of safety from numerous preclinical studies and initial clinical research:

  • Long-term genetic consistency— Stemchymal® can be ex vivo long-term cultured without genetic abnormality.
  • No tumorigenesis observed — Animal test proven.
  • Low immunogenicityIn vivo examinations have shown that Stemchymal® will not elicit inflammatory reaction. No human leukocyte antigen matching is required before administration.
  • Clinical evidence of safety — No safety issues with Stemchymal® were observed in the initial Phase I clinical trial.
Advertisements